ECRAID-Prime European Clinical Research Alliance on Infectious Diseases: Primary care adaptive platform trial for pandemics and epidemics. Updates Study Tags (field_study_tags) - Any - ADEQUATE Blog Call-outs CLIN-Net CoMeCT COVID-19 Data Ecraid ECRAID-Base EPI-Net EPOXI Mpox NeoDeco Partners People PIPELINE POS-ARI-ER POS-ARI-PC POS-cUTI POS-Disease X POS-VAP Primary Care PRUDENCE RECLAIM RECOVERY REMAP-CAP SNAP SOS Covid Training 27.10.2023 The vital role of a laboratory network in clinical research Laboratories play a multifaceted role in infectious diseases research, contributing to pathogen detection, characterisation, tre… 4.10.2023 Driving innovation and collaboration A spotlight on ECRAID-Prime’s grant management team 3.10.2023 ECRAID-Prime meets with Primary Care network representatives Two information sessions brought together seven national coordinating teams within the primary care network. 14.06.2023 ECRAID-Prime 2023 General Assembly Preparing for Europe’s first adaptive platform trial in the primary care setting 16.05.2023 ECRAID-Prime and SaNOtize to begin trial on antiviral nasal spray 23.03.2023 Ecraid hosts an open forum on adaptive platform trials at ECCMID 2023 Experts from across Europe and beyond will share their experience with several high-profile adaptive platform trials. Load More
ECRAID-Prime European Clinical Research Alliance on Infectious Diseases: Primary care adaptive platform trial for pandemics and epidemics.
27.10.2023 The vital role of a laboratory network in clinical research Laboratories play a multifaceted role in infectious diseases research, contributing to pathogen detection, characterisation, tre…
3.10.2023 ECRAID-Prime meets with Primary Care network representatives Two information sessions brought together seven national coordinating teams within the primary care network.
14.06.2023 ECRAID-Prime 2023 General Assembly Preparing for Europe’s first adaptive platform trial in the primary care setting
23.03.2023 Ecraid hosts an open forum on adaptive platform trials at ECCMID 2023 Experts from across Europe and beyond will share their experience with several high-profile adaptive platform trials.
